Los Angeles Capital Management LLC Increases Holdings in Chemed Co. (NYSE:CHE)

Los Angeles Capital Management LLC increased its position in Chemed Co. (NYSE:CHE) by 30.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,723 shares of the company’s stock after acquiring an additional 4,136 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Chemed were worth $10,651,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CHE. GAMMA Investing LLC boosted its holdings in Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust bought a new stake in Chemed during the third quarter valued at $61,000. EntryPoint Capital LLC grew its position in Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after buying an additional 18 shares in the last quarter. Mather Group LLC. increased its stake in Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after acquiring an additional 69 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after acquiring an additional 166 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

Separately, Royal Bank of Canada decreased their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the sale, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,144 shares of company stock valued at $3,002,419 over the last three months. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Performance

Shares of NYSE:CHE opened at $562.15 on Tuesday. The firm has a market capitalization of $8.46 billion, a PE ratio of 28.41, a price-to-earnings-growth ratio of 2.37 and a beta of 0.46. Chemed Co. has a 52-week low of $523.33 and a 52-week high of $654.62. The firm has a fifty day moving average of $581.72 and a 200 day moving average of $565.43.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.32 earnings per share. On average, sell-side analysts forecast that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date is Monday, November 18th. Chemed’s payout ratio is currently 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.